New Podcast Episode: Pulmonary Arterial Hypertension: Why Is This Deadly Illness Still Misdiagnosed?

Pulmonary arterial hypertension (PAH) is a life-altering condition—but far too often, it remains underdiagnosed, misunderstood, and mismanaged. In a new episode of the eXpand podcast by Respiplus (Season 6), our Executive Director, Jamie Myrah, joins host Dr. Jean Bourbeau to explore the complexities of PAH and its impact on patients across Canada.

With nearly a decade of leadership at PHA Canada, Jamie brings the front-line perspective of patients, families, and care teams navigating this challenging disease. She explains what PAH is, why it’s often missed, and how delays in diagnosis and treatment affect more than just a person’s health—they impact mental well-being, relationships, and quality of life.

🔍 In this episode, you’ll learn:

• What distinguishes PAH from other types of pulmonary hypertension

• Why it can take two years or more to get a diagnosis

• How misdiagnosis and uncertainty affect mental and social health

• Why specialized PH clinics and timely referrals are critical

• How advocacy and patient voices are driving change

Jamie also highlights PHA Canada’s mission to improve care, expand access to new treatments like sotatercept, and support the PH community with education, advocacy, and connection.

🎧 Listen now to better understand PAH—and the people living with it.